CS254969B2 - Method of 6-aryl-4,5-dihydro-3(2h)-pyridazinone derivatives production - Google Patents

Method of 6-aryl-4,5-dihydro-3(2h)-pyridazinone derivatives production Download PDF

Info

Publication number
CS254969B2
CS254969B2 CS84509A CS50984A CS254969B2 CS 254969 B2 CS254969 B2 CS 254969B2 CS 84509 A CS84509 A CS 84509A CS 50984 A CS50984 A CS 50984A CS 254969 B2 CS254969 B2 CS 254969B2
Authority
CS
Czechoslovakia
Prior art keywords
group
hydrogen
alkyl
phenyl
снз
Prior art date
Application number
CS84509A
Other languages
Czech (cs)
English (en)
Other versions
CS50984A2 (en
Inventor
Philip A Rossy
Marco Thyes
Albrecht Franke
Horst Koening
Hans D Lehmann
Josef Gries
Ludwig Friedrich
Dieter Lenke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CS50984A2 publication Critical patent/CS50984A2/cs
Publication of CS254969B2 publication Critical patent/CS254969B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Air-Conditioning For Vehicles (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS84509A 1983-01-22 1984-01-23 Method of 6-aryl-4,5-dihydro-3(2h)-pyridazinone derivatives production CS254969B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833302021 DE3302021A1 (de) 1983-01-22 1983-01-22 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
CS50984A2 CS50984A2 (en) 1987-07-16
CS254969B2 true CS254969B2 (en) 1988-02-15

Family

ID=6188901

Family Applications (1)

Application Number Title Priority Date Filing Date
CS84509A CS254969B2 (en) 1983-01-22 1984-01-23 Method of 6-aryl-4,5-dihydro-3(2h)-pyridazinone derivatives production

Country Status (18)

Country Link
US (3) US4636504A (es)
EP (1) EP0117403B1 (es)
JP (1) JPS59139365A (es)
AT (1) ATE34741T1 (es)
AU (1) AU563974B2 (es)
CA (1) CA1229597A (es)
CS (1) CS254969B2 (es)
DD (1) DD211344A5 (es)
DE (2) DE3302021A1 (es)
DK (1) DK24984A (es)
ES (1) ES8407486A1 (es)
FI (1) FI840224A (es)
GR (1) GR81690B (es)
HU (1) HU192389B (es)
IL (1) IL70744A (es)
NO (1) NO840213L (es)
SU (1) SU1648250A3 (es)
ZA (1) ZA84438B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
GB8400863D0 (en) * 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
JPS6144873A (ja) * 1984-08-10 1986-03-04 Mitsubishi Chem Ind Ltd ピリダジノン誘導体またはその塩類
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants
DE3535947A1 (de) * 1985-10-09 1987-04-09 Basf Ag Kombinationspraeparat
EP0271591B1 (de) * 1986-12-13 1989-09-20 BASF Aktiengesellschaft Kombinationspräparat
HU195645B (en) * 1985-10-30 1988-06-28 Gyogyszerkutato Intezet Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
DE3735207A1 (de) * 1987-10-17 1989-04-27 Basf Ag Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren
DE3804490A1 (de) * 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3814057A1 (de) * 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
US5700801A (en) * 1994-12-23 1997-12-23 Karl Thomae, Gmbh Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE10131133A1 (de) * 2001-06-28 2003-01-16 Bayer Ag Pyridazinone
BR0307780A (pt) 2002-02-19 2004-12-28 Ono Pharmaceutical Co Compostos derivados de piridazina fundida e medicamentos contendo os compostos como o ingrediente ativo
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
SG11201807516UA (en) 2016-03-17 2018-09-27 Hoffmann La Roche 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670043C3 (de) * 1966-01-07 1975-05-22 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 3-(Aminophenyl)-pyridazon-(6)-derivaten
IL37788A0 (en) * 1970-10-09 1971-12-29 American Cyanamid Co New pyridazinone compounds,their preparation and pharmaceutical compositions containing them
US3689652A (en) * 1970-10-09 1972-09-05 William Vincent Curran Method of lowering blood pressure in mammals
DE2123246C2 (de) * 1971-05-11 1982-11-25 Basf Ag, 6700 Ludwigshafen 6-[p-(β-Phenyläthylaminoacetylamino)-phenyl]-4,5-dihydropyridazon-(3)
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
US3824271A (en) * 1972-07-20 1974-07-16 American Cyanamid Co 3-alkyl-3-(benzoyl)propionitriles
US3888901A (en) * 1972-07-20 1975-06-10 American Cyanamid Co Process of preparing 3-alkyl-3-(benzoyl)propionitriles
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone
JPS6053022B2 (ja) * 1977-04-07 1985-11-22 ウェルファイド株式会社 ピリダジノン誘導体
DE2727481A1 (de) * 1977-06-18 1979-01-11 Basf Ag Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
CH638763A5 (de) * 1978-03-02 1983-10-14 Glasmatec Ag Einrichtung zum automatischen versiegeln von isolierglasscheiben.
DE2854191A1 (de) * 1978-12-15 1980-07-03 Basf Ag Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
DE2854475A1 (de) * 1978-12-16 1980-07-03 Basf Ag Neue 3,4-diaza-bicyclo eckige klammer auf 4.1.0 eckige klammer zu hepten-(2)- one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
DE3022176A1 (de) * 1980-06-13 1982-01-07 Basf Ag, 6700 Ludwigshafen Neue dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
DE3022177A1 (de) * 1980-06-13 1982-01-07 Basf Ag, 6700 Ludwigshafen Neue dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindung enthaltende therapeutische mittel
GR81309B (es) * 1980-06-13 1984-12-11 Basf Ag
DE3033702A1 (de) * 1980-09-08 1982-04-22 Basf Ag, 6700 Ludwigshafen Neue dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
DE3279123D1 (de) * 1981-10-20 1988-11-24 Mitsui Toatsu Chemicals Novel pyridazinone derivatives
DE3209158A1 (de) * 1982-03-13 1983-09-15 Basf Ag, 6700 Ludwigshafen Neue 6-aryl-4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung
DE3209159A1 (de) * 1982-03-13 1983-09-15 Basf Ag, 6700 Ludwigshafen Neue 6-aryl-4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung

Also Published As

Publication number Publication date
IL70744A0 (en) 1984-04-30
EP0117403B1 (de) 1988-06-01
ATE34741T1 (de) 1988-06-15
AU563974B2 (en) 1987-07-30
SU1648250A3 (ru) 1991-05-07
DE3471655D1 (en) 1988-07-07
US4636504A (en) 1987-01-13
FI840224A0 (fi) 1984-01-19
JPS59139365A (ja) 1984-08-10
FI840224A (fi) 1984-07-23
DE3302021A1 (de) 1984-07-26
CA1229597A (en) 1987-11-24
DD211344A5 (de) 1984-07-11
HU192389B (en) 1987-06-29
NO840213L (no) 1984-07-23
DK24984A (da) 1984-07-23
EP0117403A1 (de) 1984-09-05
ES529055A0 (es) 1984-09-16
US4873246A (en) 1989-10-10
IL70744A (en) 1987-12-20
ES8407486A1 (es) 1984-09-16
USRE33476E (en) 1990-12-04
DK24984D0 (da) 1984-01-20
GR81690B (es) 1984-12-12
ZA84438B (en) 1984-09-26
CS50984A2 (en) 1987-07-16
AU2366084A (en) 1984-07-26

Similar Documents

Publication Publication Date Title
CS254969B2 (en) Method of 6-aryl-4,5-dihydro-3(2h)-pyridazinone derivatives production
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
PT85483B (pt) Processo para a preparacao de novos derivados da 1,4-dihidropiridina com actividade alfa1-antagonista e agonista do calcio e de composicoes farmaceuticas que os contem
AU2017405244C9 (en) Novel pyrrolopyridine derivative, method for producing same, and use thereof
GB2190677A (en) 1-(hydroxystyryl)-5h-2,3-benzodiazepine derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
US5576327A (en) Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
DE69614503T2 (de) Carbostyrilderivate als antithrombotische mittel
DK149810B (da) Analogifremgangsmaade til fremstilling af basisk substituerede 3-oxopyridaziner og deres fysiologisk acceptable syreadditionssalte
KR840000705B1 (ko) 신규 피리미딘 유도체의 제조방법
KR870001681B1 (ko) 히단토인 유도체의 제조방법
DE68921198T2 (de) Benzothiadiazepin-derivate.
KR20240109270A (ko) Egfr 단백질 분해용 화합물 및 이의 용도
IE50864B1 (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols,their preparation and therapeutic agents containing these compounds
EP0513691B1 (en) Anti-ulcer agent
EP0089528B1 (de) 6-Aryl-4,5-dihydro-3(2H)-pyridazinone,ihre Herstellung und Verwendung
EP0589908B1 (de) Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung
DE2854191A1 (de) Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
JPH0696555B2 (ja) カルボスチリル誘導体
US4533664A (en) Antithrombotic N-(6-chloro-pyrazin-2-yl)-4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide derivatives, composition, and method of use
JPH0373550B2 (es)
US4425342A (en) 1-(Substituted) piperazine-4-benzenesulfinamides, compositions and method of use
EP0471841B1 (en) Sulfonamide derivative and pharmaceutical composition containing the same
US4607031A (en) Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
WO1997043292A1 (en) New thiazolopyridines
IE64349B1 (en) New benzopyrrolidinone derivatives a process for the preparation therof and pharmaceutical compositions containing them